Keyword: Memorial Sloan Kettering Cancer Center
Officials at Memorial Sloan Kettering fostered a culture where profits were more important than patient care and research, a new external report on conflicts of interest at the institution found.
José Baselga, M.D., has a new job in the pharmaceutical industry after an ethics scandal forced him out at Memorial Sloan Kettering Cancer Center.
One of the nation’s top cancer hospitals has grappled with how to bring breakthrough treatments to market while remaining true to its mission.
Leading medical figures have failed to report financial relationships when their studies are published in journals, according to an investigation.
Billionaire philanthropist Sean Parker explains why he's so bullish on cell therapy as part of his Parker Institute for Cancer Immunotherapy.
The DOJ approved the $69 billion CVS-Aetna merger on Wednesday after Aetna agreed to sell off its Part D business, and other physician practice news.
A new "economically significant" interoperability rule landed at OMB on Friday.
The fall of two prominent researchers raises concerns about how medical journals enforce conflict disclosures and assure the validity of research.
A Memorial Sloan Kettering Cancer Center official did not report millions in payments from companies and more health news from around the web.
Glassdoor released its list of best places to work in 2018, and a number of healthcare organizations made the cut.
